Abstract

The vascular endothelium is a dynamic structure which lines the entire circulatory and lymphatic systems and interacts with local and systemic stimuli. It plays an important role in such processes as vasoconstriction/vasorelaxation, inflammation, cell proliferation, and hemostasis. Dysfunction of endothelial cells contributes to the development of different diseases including hypertension, atherosclerosis, and peripheral arterial disease, which are commonly seen in patients with chronic diabetes. Various risk factors including low density lipoprotein oxidation, inflammation, thrombosis as well as imbalance between NO and endothelin production are considered to induce the VE dysfunction and associated cardiovascular diseases. Although several interventions such as thrombolytic agents, anti-inflammatory agents, antioxidants, NO donors, endothelin inhibitors and stem cell therapy are used for the treatment of hypertension, atherosclerosis and peripheral artery disease, none of these have been found to exert satisfactory beneficial effects. Thus a great deal of research work needs to be carried out to define the exact molecular targets and develop newer therapies for the treatment of hypertension, atherosclerosis and peripheral vascular disease.

Highlights

  • Peripheral arterial disease (PAD) is commonly associated with hypertension and atherosclerosis, the vascular endothelium (VE) has been shown to play a critical role in its pathogenesis

  • Since atherosclerotic risk factors such as alterations in lipoproteins, influence the endothelium and lead to the development of atherosclerosis via endothelial dysfunction, the use of statins to correct the presence of hyperlipidemia, which improves the bioavailability of nitric oxide (NO) [39], is the current strategy for the treatment of atherosclerosis

  • The impaired integrity and function of the VE plays a critical role in the development of HTN, atherosclerosis and peripheral arterial disease (PAD), which cardiovascular diseases are frequently observed in diabetic patients

Read more

Summary

Introduction

Peripheral arterial disease (PAD) is commonly associated with hypertension and atherosclerosis, the vascular endothelium (VE) has been shown to play a critical role in its pathogenesis. The expression of tissue factor on the endothelial surface through endotoxin and cytokine pathways are attenuated by NO, which is important in systemic inflammatory states to maintain blood flow to the peripheral tissues.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.